- Home
- F vs TAK Comparison
F vs TAK Comparison
Compare F & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | F | TAK |
|---|---|---|
| Founded | 1903 | 1781 |
| Country | United States | Japan |
| Employees | 169000 | 47455 |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.2B | 56.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | F | TAK |
|---|---|---|
| Price | $12.18 | $18.08 |
| Analyst Decision | Hold | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $13.09 | N/A |
| AVG Volume (30 Days) | ★ 67.4M | 2.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.94% | 2.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.04 |
| Revenue Next Year | $0.95 | $0.92 |
| P/E Ratio | ★ N/A | $41.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.44 | $12.99 |
| 52 Week High | $14.80 | $18.82 |
Technical Indicators
Market Signals| Indicator | F | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 30.72 | 53.16 |
| Support Level | $11.19 | $14.78 |
| Resistance Level | $14.18 | $18.82 |
| Average True Range (ATR) | 0.43 | 0.25 |
| MACD | -0.23 | -0.17 |
| Stochastic Oscillator | 10.29 | 42.72 |
Price Performance
Historical ComparisonAbout F Ford Motor Company
Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022, the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor. The company has over 13% market share in the United States, about 10% share in the UK, and just over 1% share in China including Taiwan and unconsolidated affiliates. Sales in the US made up about 65% of 2025 total company revenue. Ford has about 169,000 employees, including about 56,300 UAW employees, and is based in Dearborn, Michigan.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.